CHI3L1 and metabolic dysfunction-associated steatotic liver disease: That our WTC-PM exposed patients with NAFLD had lower YLK-40 levels than controls may seem inconsistent with the observation that YKL-40 levels are usually increased in other liver diseases [28-30].